Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

244
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
244
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

272
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
272
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

289
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
289
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

235
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
235
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

829
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
829

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Omics signature of new-onset mild cognitive impairment and dementia in a population-based study.

Scientific reports·2026
Same author

Multiplex profiling of 16 immune checkpoints identifies novel serum biomarker panels for breast cancer detection and TNBC stratification: A case-control study.

PloS one·2026
Same author

Differential metabolomic prediction of outcomes in HFpEF and HFrEF: a prospective international multi-ethnic cohort study.

Cardiovascular research·2026
Same author

Breast and ovarian cancers: toward a multi-cancer early detection test.

Frontiers in immunology·2026
Same author

Small LLMs can be good coldstart recommenders.

Frontiers in artificial intelligence·2026
Same author

Development and Validation of Machine Learning Models for Predicting Early Cognitive Decline Using Home Sensor-Derived Behavioral Data: Sensors in-Home for Elder Wellbeing (SINEW) Cohort Study.

JMIR research protocols·2026

Related Experiment Video

Updated: Feb 18, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.3K

Health and disease phenotyping in old age using a cluster network analysis.

Jesus Felix Valenzuela1, Christopher Monterola1,2, Victor Joo Chuan Tong3

  • 1Institute of High Performance Computing, Computing Science Department, 1 Fusionopolis Way, #16-16 Connexis North, 138632, Singapore, Singapore.

Scientific Reports
|November 17, 2017
PubMed
Summary

This study analyzed network relationships among factors influencing human aging in adults over 55. It identified six key themes linking physiological systems to health outcomes, offering insights into healthy and unhealthy aging patterns.

More Related Videos

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

8.8K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.4K

Related Experiment Videos

Last Updated: Feb 18, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.3K
A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

8.8K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.4K

Area of Science:

  • Gerontology
  • Network Science
  • Biostatistics

Background:

  • Human aging is a multifaceted process driven by complex interactions between biological, psychological, and lifestyle factors.
  • Understanding these interrelationships is crucial for developing targeted interventions and improving quality of life in older adults.

Purpose of the Study:

  • To conduct a network analysis of physiological and psychological functions, disease, disability, quality of life, and lifestyle/behavioral risk factors in individuals aged 55 and above.
  • To identify clusters and hierarchical themes within the complex network of aging-related variables.

Main Methods:

  • Network analysis of 3,270 subjects aged ≥55 years, examining associations between numerical and categorical variables using effect-size measures.
  • Construction of a pairwise effect-size network and minimum spanning tree to identify variable clusters.
  • Correspondence analysis to compare coarse-grained and fine-grained network structures.

Main Results:

  • Identified clusters from the minimum spanning tree that mapped to physiological and syndromic states.
  • Hierarchical ordering revealed six common themes reflecting interactions with physiological systems and substrates of age-associated morbidity.
  • Demonstrated correspondence between coarse-grained and fine-grained network structures.

Conclusions:

  • The study provides a network-based framework for understanding the complex interplay of factors in human aging.
  • Findings offer a foundation for future research incorporating biomarkers to develop typologies of healthy and unhealthy aging.
  • The identified themes highlight key areas for intervention to mitigate age-associated decline and enhance well-being.